Cross-species immune recognition between plasmodium vivax duffy binding protein 
antibodies and the plasmodium falciparum surface antigen VAR2CSA

Gnidehou, Sédami; Mitran, Catherine J.; Arango, Eliana; Banman, Shanna; Mena, Angie; Medawar, Evelyn; Lima, Barbara A. S.; Doritchamou, Justin; Rajwani, Jahanara; Jin, Albert; Gavina, Kenneth; Ntumngia, Francis; Duffy, Patrick; Narum, David; Ndam , Nicaise Tuikue; Nielsen, Morten A.; Salanti, Ali; Kano, Flora S.; Carvalho, Luzia H.; Adams, John H.; Maestre, Amanda; Good, Michael F.; Yanow, Stephanie K.

doi:10.1093/infdis/jiy467

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Cross-species immune recognition between plasmodium vivax duffy binding protein antibodies and the plasmodium falciparum surface antigen VAR2CSA

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Gnidehou, S., Mitran, C. J., Arango, E., Banman, S., Mena, A., Medawar, E., et al. (2019). Cross-species immune recognition between plasmodium vivax duffy binding protein antibodies and the plasmodium falciparum surface antigen VAR2CSA. The Journal of Infectious Diseases, 219(1), 110-120. doi:10.1093/infdis/jiy467.

Cite as: https://hdl.handle.net/21.11116/0000-0002-BB57-A

Abstract

Background

In pregnancy, Plasmodium falciparum parasites express the surface antigen VAR2CSA, which mediates adherence of red blood cells to chondroitin sulfate A (CSA) in the placenta. VAR2CSA antibodies are generally acquired during infection in pregnancy and are associated with protection from placental malaria. We observed previously that men and children in Colombia also had antibodies to VAR2CSA, but the origin of these antibodies was unknown. Here, we tested whether infection with Plasmodium vivax is an alternative mechanism of acquisition of VAR2CSA antibodies.
Methods

We analyzed sera from nonpregnant Colombians and Brazilians exposed to P. vivax and monoclonal antibodies raised against P. vivax Duffy binding protein (PvDBP). Cross-reactivity to VAR2CSA was characterized by enzyme-linked immunosorbent assay, immunofluorescence assay, and flow cytometry, and antibodies were tested for inhibition of parasite binding to CSA.
Results

Over 50% of individuals had antibodies that recognized VAR2CSA. Affinity-purified PvDBP human antibodies and a PvDBP monoclonal antibody recognized VAR2CSA, showing that PvDBP can give rise to cross-reactive antibodies. Importantly, the monoclonal antibody inhibited parasite binding to CSA, which is the primary in vitro correlate of protection from placental malaria.
Conclusions

These data suggest that PvDBP induces antibodies that functionally recognize VAR2CSA, revealing a novel mechanism of cross-species immune recognition to falciparum malaria.